Plain-English translation of NCT07517198 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 1 — Testing in a small group (usually 20–80 people) to find a safe dose and watch for side effects.
This is a Phase 1 trial testing a new experimental medication called in people with various advanced solid tumors. The main goal is to find the safest dose of this medication and understand how well it works. Researchers will start with a low dose and gradually increase it, carefully watching for side effects and benefits.
Many people with advanced cancers need new treatment options when standard therapies stop working or cause too many side effects. This trial is designed to determine whether this new medication could become a helpful option for patients with these hard-to-treat cancers.
You likely qualify if…
You likely don't qualify if…
If you join this trial, you will receive as a treatment at the study center. The study starts with a low dose and gradually increases it for different groups of participants—this helps researchers find the safest and most effective dose. You'll have regular visits for check-ups, blood tests, and imaging scans to monitor how you're responding and check for side effects. The exact schedule and duration will be discussed with the research team at your study visits.
AI-generated summary from trial data · Jun 16, 2026 · Not medical advice
United States